Tamiflu Range 30 mg. 45 mg. 75 mg. 6 mg/mℓ Capsules. Powder for Oral Suspension
PDF Leaflet Revision Date: 19 February 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment and prophylaxis of influenza.
Dosage (summary)
Adults: 75 mg twice daily for 5 days. Children: Dosing varies by weight.
Onset of Action / Duration
Onset: 30 mins, Duration: 6-8 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
- Immunocompromised patients
Pregnancy & Breastfeeding
Use in pregnancy if benefits outweigh risks; low levels in breast milk.
Key Drug Interactions
- Probenecid
- Amoxicillin
- Paracetamol
Contraindications
- Hypersensitivity to oseltamivir
Common side effects
- Nausea
- Vomiting
- Headache
Counselling Points
- Monitor for abnormal behavior, especially in children.
- Not a substitute for vaccination.
- Take within 2 days of symptom onset.
Serious warnings
- Neuropsychiatric events
- Resistance in influenza viruses
Important Disclaimer
The Tamiflu Range 30 mg. 45 mg. 75 mg. 6 mg/mℓ Capsules. Powder for Oral Suspension professional information leaflet below is the property of Roche Products and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
